Neuralink, a biotechnology company backed by Elon Musk, has announced a $280 million Series D funding round led by Peter Thiel's Founders Fund. The California-based company develops implantable brain-computer interfaces to enable direct communication between the brain and external devices. The funds will be used to help people with paralysis or other neurological conditions regain independence by controlling computers and mobile devices using their brain activity. However, the company has faced controversy over animal testing and its Institutional Animal Care and Use Committee.
All Comments